This book examines in detail the psychosocial impacts of cancer and its management, explaining the relevance of psycho-oncology during all stages from diagnosis and treatment through to cancer survivorship and rehabilitation and end-of-life care. This new edition has been revised throughout to reflect the latest knowledge and places particular emphasis on patients’ perspectives and what professionals can learn from patients. Readers will find information on a variety of psycho-oncological interventions, and detailed attention is paid to quality of life and patient-reported outcomes (as key benchmarks for successful coping) and to the fear of progression during and after therapy. Entirely new chapters focus on the psychological impact of individualized therapies in oncology, communication skills training, medical risk communication, and current research approaches in psycho-oncology. Written by leading experts in the field, the book will serve as a valuable resource for all health care professionals who work with patients and their relatives in the field of psychosocial cancer care and oncology.

This comprehensive guide describes the aftercare that is appropriate in young cancer patients and discusses in detail the risk and detection of treatment sequelae. It explains the impacts on body and mind of both the disease itself and the different risk-adapted cancer treatments currently in use. Clear guidance is provided on diagnosis and management of the principal treatment-related toxicities in different organs and organ systems and for a wide variety of tumor types. In addition, the role of genetic polymorphisms in the development of adverse therapy-related outcomes is explored, and advice offered on genetic counselling. As the number of long-term survivors of childhood cancer and of cancer in young adults continues to grow, so issues surrounding potential sequelae, second malignancies, and quality of life are becoming ever more important. All practitioners involved in the care of young cancer patients will find this book to be a helpful source of up-to-date information and assistance.

Different people feel different emotions when they are diagnosed with cancer. Both today and a century ago, fear and hope, shame and disgust, sadness and joy are and were the emotions experienced by many cancer patients and their loved ones. But these emotions do not just have significance for the people who feel them. They have also exerted a surprisingly profound influence on how hospitals and laboratories dealt with cancer, how early detection campaigns portrayed it, and how doctors talked about it with their patients. Bettina Hitzer details the history of cancer and emotions in twentieth-century Germany and thus follows the cancer-associated transformations of emotional regimes, emotional politics, and emotional experiences through five different political systems. In doing so, the study underscores that political caesuras resonate in the immediate corporeality of the history of emotions.

The second international symposium on "Supportive Care in Cancer Patients" took place March 1-3, 1990-again in St. Gallen in eastern Switzerland. It was an honor once more to welcome dozens of internationally recognized experts in the field and more than 800 participants from over 30 countries around the world: Australia, Canada, China, USSR, USA and many countries in Europe. The international nature of the grade facilitated lively and exciting contributions and critical discussions, aimed at fostering professional knowledge and skills and rethinking our personal attitudes toward cancer patients in all stages of their disease. Cancer patients need various types of tailored support, whether during active initial (curative) therapies, in phases of worrying relapsing disease, or during the demanding terminal stage of their illness. The symposium tried to bridge the strange "gap" between "curative" and "palliative" cancer care: it must be our aim to be and remain "supportive" for our patients during both curative and palliative treatment strategies! This requires extended knowledge and even more and flexible professional skills. The symposium was designed to promote improved approaches that are helpful and supportive for all our oncology patients, not just for a selected disease-or stage dependent minority.

This book provides surgeons and oncologists with a well-founded and detailed overview of the available treatment options for peritoneal malignancy and differential selection of the appropriate forms of therapy. Systemic chemotherapy options are also considered, as are surgical cytoreduction (CRS) and all forms of intraperitoneal chemotherapy (IPC) especially hyperthermic IPC (HIPEC), and immunotherapy, including specific procedures such as PIPAC. Subsequent chapters address perioperative care, complications and recurrences, as well as psycho-oncological, palliative medical and nursing care. The process of parietal and visceral peritonectomy in the large and small intestine is additionally illustrated by three video clips accessible online. Covering a broad range of aspects, including peritoneal metastasis and intraperitoneal chemotherapy, the book offers a valuable tool for surgeons, oncologists and anesthesiologists alike.